Statistics and Consulting Unit
Boston University
The Boston University Statistics and Consulting Unit is a multidisciplinary research unit with primary focus on medical research including epidemiology, cardiovascular research, aging, drug development and testing, clinical trials, dental and oral research, outcomes research, quality of life and psychiatric rehabilitation. It is a Unit within the Mathematics and Statistics Department and has strong links to the academic programs within the Department. In addition it has substantial ties to the Epidemiology and
Biostatistics Department of the School of Public Health, having many of its members as faculty members of that department. The Unit has ongoing extensive connections with the Framingham Heart Study, Boston University’s Center for Psychiatric Rehabilitation, Forsyth Dental Institute, the Food and Drug Administration and a number of Pharmaceutical companies. The Unit also housed the editorial offices of the journal, Statistics in Medicine.
The Unit directs the Data Management and Statistical Analysis activities of the Framingham Heart Study. This illustrious cardiovascular epidemiological study began in 1948 and
continues to follow subjects, their offspring and the offspring’s spouses to obtain longitudinal data on the risk factors and development of cardiovascular disease.
In addition the Unit has expertise in designing and analyzing clinical trials associated with the development and testing of drugs, biologics and devices. Members of the Unit have affiliation with the Food and Drug Administration Bureaus of Drugs, Biologics and Devices,
a number of pharmaceutical houses such as Pfizer, Merck, and Roche, and also with Contract Research Organizations such as Quintlies. In particular, it has long standing interest and background in Cardiovascular and Dental and Oral clinical trials.
The Unit is also the Data Management and Analysis Unit for the Roche REWARD Study. This study is a large registry collecting longitudinal data on Obesity and weight management
programs.